Literature DB >> 25106756

Neutrophil responses to aspergillosis: new roles for old players.

Cristina Cunha1, Oliver Kurzai, Jürgen Löffler, Franco Aversa, Luigina Romani, Agostinho Carvalho.   

Abstract

Neutrophils are professional phagocytic cells that play a crucial role in innate immunity. Through an assortment of antifungal effector mechanisms, neutrophils are essential in controlling the early stages of fungal infection. These mechanisms range from the production of reactive oxygen intermediates and release of antimicrobial enzymes to the formation of complex extracellular traps that aid in the elimination of the fungus. Their importance in antifungal immunity is supported by the extreme susceptibility to infection of patients with primary (e.g., chronic granulomatous disease) or acquired (e.g., undergoing immunosuppressive therapy) neutrophil deficiency. More recently, common genetic variants affecting neutrophil antifungal capacity have also been disclosed as major risk factors for aspergillosis in conditions of generalized immune deficiency. The present review revisits the role of neutrophils in the host response against Aspergillus and highlights the consequences of their deficiency in susceptibility to aspergillosis.

Entities:  

Mesh:

Year:  2014        PMID: 25106756     DOI: 10.1007/s11046-014-9796-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  53 in total

Review 1.  Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans.

Authors:  Shanshan Luo; Christine Skerka; Oliver Kurzai; Peter F Zipfel
Journal:  Mol Immunol       Date:  2013-06-26       Impact factor: 4.407

2.  IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoids.

Authors:  Michael R Edwards; Naofumi Mukaida; Malcolm Johnson; Sebastian L Johnston
Journal:  Pulm Pharmacol Ther       Date:  2005-03-17       Impact factor: 3.410

3.  Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia.

Authors:  Colin R Bonnett; E Jean Cornish; Allen G Harmsen; James B Burritt
Journal:  Infect Immun       Date:  2006-08-18       Impact factor: 3.441

4.  In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis.

Authors:  Oumaïma Ibrahim-Granet; Grégory Jouvion; Tobias M Hohl; Sabrina Droin-Bergère; François Philippart; Oh Yoen Kim; Minou Adib-Conquy; Reto Schwendener; Jean-Marc Cavaillon; Matthias Brock
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

5.  Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus.

Authors:  Y Aratani; F Kura; H Watanabe; H Akagawa; Y Takano; K Suzuki; M C Dinauer; N Maeda; H Koyama
Journal:  Med Mycol       Date:  2002-12       Impact factor: 4.076

6.  Restoration of NET formation by gene therapy in CGD controls aspergillosis.

Authors:  Matteo Bianchi; Abdul Hakkim; Volker Brinkmann; Ulrich Siler; Reinhard A Seger; Arturo Zychlinsky; Janine Reichenbach
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

7.  Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

Authors:  Luigina Romani; Francesca Fallarino; Antonella De Luca; Claudia Montagnoli; Carmen D'Angelo; Teresa Zelante; Carmine Vacca; Francesco Bistoni; Maria C Fioretti; Ursula Grohmann; Brahm H Segal; Paolo Puccetti
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

8.  Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense.

Authors:  R Robert Vethanayagam; Nikolaos G Almyroudis; Melissa J Grimm; David C Lewandowski; Christine T N Pham; Timothy S Blackwell; Ruta Petraitiene; Vidmantas Petraitis; Thomas J Walsh; Constantin F Urban; Brahm H Segal
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

9.  Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus.

Authors:  Thierry Fontaine; Aurélie Delangle; Catherine Simenel; Bernadette Coddeville; Sandra J van Vliet; Yvette van Kooyk; Silvia Bozza; Silvia Moretti; Flavio Schwarz; Coline Trichot; Markus Aebi; Muriel Delepierre; Carole Elbim; Luigina Romani; Jean-Paul Latgé
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

10.  Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum.

Authors:  Sixto M Leal; Sanhita Roy; Chairut Vareechon; Steven deJesus Carrion; Heather Clark; Manuel S Lopez-Berges; Antonio Di Pietro; Antonio diPietro; Marcus Schrettl; Nicola Beckmann; Bernhard Redl; Hubertus Haas; Eric Pearlman
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

View more
  17 in total

1.  Human Neutrophils Are Primed by Chemoattractant Gradients for Blocking the Growth of Aspergillus fumigatus.

Authors:  Caroline N Jones; Laurie Dimisko; Kevin Forrest; Kevin Judice; Mark C Poznansky; James F Markmann; Jatin M Vyas; Daniel Irimia
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

2.  Advances against aspergillosis: biology, host response, diagnosis and treatment.

Authors:  David S Askew; Dimitrios P Kontoyiannis; Karl V Clemons
Journal:  Mycopathologia       Date:  2014-10-07       Impact factor: 2.574

Review 3.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

4.  How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.

Authors:  Ana Fernández-Cruz; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

5.  The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.

Authors:  Naruhiko Ishiwada; Kenichi Takeshita; Takashi Yaguchi; Koo Nagasawa; Noriko Takeuchi; Haruka Hishiki; Akira Watanabe; Katsuhiko Kamei; Naoki Shimojo
Journal:  Mycopathologia       Date:  2015-11-13       Impact factor: 2.574

Review 6.  Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis.

Authors:  Ana Oliveira-Coelho; Fernando Rodrigues; António Campos; João F Lacerda; Agostinho Carvalho; Cristina Cunha
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640

7.  Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions.

Authors:  Teresa Lehnert; Sandra Timme; Johannes Pollmächer; Kerstin Hünniger; Oliver Kurzai; Marc Thilo Figge
Journal:  Front Microbiol       Date:  2015-06-19       Impact factor: 5.640

8.  Defining the transcriptomic landscape of Candida glabrata by RNA-Seq.

Authors:  Jörg Linde; Seána Duggan; Michael Weber; Fabian Horn; Patricia Sieber; Daniela Hellwig; Konstantin Riege; Manja Marz; Ronny Martin; Reinhard Guthke; Oliver Kurzai
Journal:  Nucleic Acids Res       Date:  2015-01-13       Impact factor: 16.971

9.  FleA Expression in Aspergillus fumigatus Is Recognized by Fucosylated Structures on Mucins and Macrophages to Prevent Lung Infection.

Authors:  Sheena C Kerr; Gregory J Fischer; Meenal Sinha; Orla McCabe; Jonathan M Palmer; Tsokyi Choera; Fang Yun Lim; Michaela Wimmerova; Stephen D Carrington; Shaopeng Yuan; Clifford A Lowell; Stefan Oscarson; Nancy P Keller; John V Fahy
Journal:  PLoS Pathog       Date:  2016-04-08       Impact factor: 6.823

10.  Mitochondrial Reactive Oxygen Species Enhance Alveolar Macrophage Activity against Aspergillus fumigatus but Are Dispensable for Host Protection.

Authors:  Neta Shlezinger; Tobias M Hohl
Journal:  mSphere       Date:  2021-06-02       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.